Odyssey Health, Inc.
ODYY
$0.03
$0.0011.49%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -47.67% | 168.65% | -65.33% | -85.95% | -29.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -47.67% | 165.59% | -65.33% | -86.47% | -31.61% |
| Operating Income | 47.67% | -165.59% | 65.33% | 86.47% | 31.61% |
| Income Before Tax | 52.56% | 98.02% | 70.12% | -101.66% | -89.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.56% | 98.02% | 70.12% | -101.66% | -89.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.56% | 98.02% | 70.12% | -101.66% | -89.39% |
| EBIT | 47.67% | -165.59% | 65.33% | 86.47% | 31.61% |
| EBITDA | -- | -165.42% | 65.44% | 86.50% | 31.58% |
| EPS Basic | 52.58% | 98.03% | 70.37% | -101.46% | -46.97% |
| Normalized Basic EPS | 28.21% | -244.44% | 62.07% | 85.23% | 51.25% |
| EPS Diluted | 54.00% | 92.12% | 76.00% | -101.79% | 0.00% |
| Normalized Diluted EPS | 28.21% | -244.44% | 62.07% | 81.69% | 51.25% |
| Average Basic Shares Outstanding | 1.27% | -0.05% | 0.89% | 13.85% | 29.27% |
| Average Diluted Shares Outstanding | 1.27% | -0.05% | 0.89% | -8.19% | 29.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |